Aflac Stock And Other U.S. Insurers With More Upside From Higher Bond Yields

Long term U.S. yields have surged, bond funds like TLT are under pressure, and money is pouring into fixed income just as weaker jobs data hints at a turning point. That mix is shaking up how investors think about income, risk, and equity exposure. If you care about what higher long yields and a peak rates story might mean for your portfolio, keep reading. This article unpacks three U.S. life insurance and annuity stocks from our screener that look particularly exposed to these crosscurrents, and explains how the same macro shock can create very different stories for each stock.

The three stocks below are just a small sample from this theme. The full screen surfaced 30 more U.S. life insurers and annuity providers with equally compelling narratives that are not covered here. If you want to identify your own highest conviction ideas from this group, head straight to the U.S. Life Insurers And Annuity Providers Benefiting From Higher Long-Term Yields screener.

Aflac (AFL)

Aflac appears in this higher-yield-focused screen because its supplemental health and life products are supported by a sizeable long-term investment portfolio. As a result, changes in bond income can matter almost as much as policy sales for how investors evaluate the stock.

Aflac is a supplemental health and life insurer with operations split between Aflac Japan, which generated about US$8.9b of revenue, and Aflac U.S. on roughly US$7.0b, with a further US$1.2b from corporate and other lines. This gives the group a market value near US$55.7b.

For investors monitoring how higher long-term yields could influence Aflac, one portfolio move highlights how management is seeking to turn rate volatility into a more durable income lever.

"The repositioning of about 5% of Aflac’s global investment portfolio, using foreign exchange gains on dollar assets to support moves out of older bonds, is expected to add over US$50 million of annual net investment income on a run rate basis."

The key question is what happens if this relatively quiet shift in how the investment book is balanced against claims and capital costs changes the margin profile more than premiums do.

If that shift in economics is what you care about, read the full narrative for Aflac to learn how Aflac’s income engine could be quietly decoupling from headline premiums.

Globe Life (GL)

Globe Life is a U.S. life and supplemental health insurer built around long-dated policies that are backed by sizeable bond portfolios, which puts it squarely in focus for investors tracking how higher long-term yields ripple through insurers’ income statements.

Globe Life Inc. offers life and supplemental health insurance to U.S. middle-income households, earning about US$3.4b from life coverage, US$1.6b from health products, and US$1.2b from investment income, giving the business a roughly US$12.7b market value.

"Planned deployment of AI applications across administration, underwriting and sales support is aimed at lowering the administrative expense ratio from about 7.3% of premium and lifting agent productivity, which could support higher net margins and net operating income over time."

The real swing factor is how one pressure point in the health book ultimately feeds through to those future margin ambitions investors are banking on.

That hinge point on margins is where Globe Life’s story gets interesting, and the full narrative for Globe Life shows how AI and long yields could reshape earnings power.

F&G Annuities & Life (FG)

F&G Annuities & Life focuses on U.S. annuity and life insurance products whose earnings and spreads can be directly influenced by higher long-term yields. The group generated about US$6.1b of life insurance revenue and carries a market value near US$2.9b.

F&G Annuities & Life sits right in the sweet spot of this higher-yield theme because its fixed indexed and other annuities depend on the gap between what it earns on long bonds and what it credits to policyholders. This puts a lot of weight on what happens when that gap moves even slightly.

When that spread is doing the real work, the analyst forecasts for F&G Annuities & Life shows how F&G Annuities & Life’s earnings power could accelerate if that gap widens further.

Curious About What You Might Be Missing Next

Fresh breakout stories rarely stay under the radar for long. Momentum shifts, prices start flying, and the best entry points get caught by early movers. Act now.

• Capture potential big swings in smaller names before the crowd starts chasing them by scanning the 9 elite penny stocks with strong financials while prices still look early stage.
• Ride long-term structural demand in critical materials by tracking producers in the 9 elite penny stocks with strong financials while attention is still dropping elsewhere.
• Position ahead of possible income-focused momentum by reviewing the curated 7 dividend fortresses while yields and coverage metrics still look under the radar for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com